Perceptions and acceptability of microsampling for remote monitoring in patients with plasma cell dyscrasias

In this webinar, we discuss the importance of involving patients in our research and the valuable insight we have been able to gain.

Multiple myeloma is categorized as a relapsing-remitting blood cancer and requires frequent blood tests. Microsampling introduces a self-administered, blood sampling technique that has potential to revolutionize multiple myeloma monitoring.

In this presentation, we will discuss how we incorporated patient and public involvement (PPI) into our study. PPI contributors aided in the development of our research protocol and questionnaire, and reviewed patient-facing documents. Feedback from these representatives proved to be insightful and the consensus was that microsampling would be a welcome addition to the routine clinical care of multiple myeloma.

Of interest to:

Clinical researchers and trials teams aiming to incorporate Patient and Public Involvement (PPI) in research processes
Healthcare providers seeking to integrate microsampling methods within patient pathways
Developers of microsampling tools looking to understand patient perspectives
Members of the public and/or patients interested in getting involved in research

Your details

By submitting this form you are agreeing to our Terms & Conditions and Privacy Policy, and agree to receiving relevant emails from The Evidence Base about the latest news and editorial features.

Terms & Conditions

I agree to receive third party emails to keep me informed of relevant products and services relevant to my industry.

I agree for my registration data to be transferred to the lead partner organization (PCSIG).

Subscribing to

Confirm sign-up

What you will learn:

The importance of working collaboratively with patients through various stages of a trial
How to run focus groups for patient and public engagement
Myeloma patient insight to current patient monitoring pathways
Myeloma patient perspectives and satisfaction of remote monitoring

Speaker:

Nithya Paranthaman
Senior Scientific Officer, The Royal Marsden Hospital

Nithya Paranthaman is currently a Senior Scientific Officer at The Royal Marsden Hospital (RMH; Sutton, UK). Nithya’s research focuses on developing remote patient monitoring schemes in cancer pathways. She completed her PhD at the Institute of Cancer Research (ICR; Sutton, UK) in 2023. Her PhD project included method development and optimization of microsampling tools to monitor disease status in multiple myeloma patients. Prior to joining the RMH, she worked at Sanofi Genzyme (MA, USA) and Novartis (NJ, USA). Her research interests lie at the intersection of clinical research and patient-centricity.

Moderated by:

Neil Spooner
Founder, Patient Centric Sampling Interest Group

Neil Spooner (PhD, CChem, FRSC) is the Co-founder, Chair and director of the Patient Centric Sampling Interest Group, CIC, a not-for-profit organisation that brings together a variety of interested parties who wish to develop and promote the use of patient centric sampling technologies for blood, plasma and other human matrices to better facilitate the advancement of human healthcare and well-being. Neil is also the founder and Director of Spooner Bioanalytical Solutions, a consultancy based in Hertford, UK.  In addition, Neil is a Senior Visiting Research Fellow at the School of Life and Medical Sciences, University of Hertfordshire (Hertfordshire, UK), the Editor in Chief of Bioanalysis Journal and the Chair of the Reid Bioanalytical Forum. He has published extensively, with over 70 peer reviewed manuscripts and more than 50 podium presentations at international Conferences and Symposia.

Share this webinar